Los Angeles Capital Management LLC Acquires Shares of 5,310 Solventum Co. (NYSE:SOLV)

Los Angeles Capital Management LLC acquired a new stake in Solventum Co. (NYSE:SOLV) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 5,310 shares of the company’s stock, valued at approximately $281,000.

Other institutional investors also recently modified their holdings of the company. Price T Rowe Associates Inc. MD acquired a new stake in shares of Solventum during the 1st quarter worth approximately $5,889,000. Mitsubishi UFJ Trust & Banking Corp acquired a new stake in shares of Solventum during the 1st quarter worth approximately $5,747,000. CWM LLC acquired a new stake in shares of Solventum during the 2nd quarter worth approximately $473,000. Great Valley Advisor Group Inc. bought a new position in Solventum during the 2nd quarter worth approximately $493,000. Finally, First Horizon Advisors Inc. bought a new position in Solventum during the 2nd quarter worth approximately $58,000.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on the stock. BTIG Research assumed coverage on shares of Solventum in a research note on Thursday, September 5th. They set a “neutral” rating on the stock. Bank of America reduced their price objective on shares of Solventum from $70.00 to $60.00 and set a “neutral” rating on the stock in a research note on Tuesday, June 25th. The Goldman Sachs Group lifted their price target on shares of Solventum from $48.00 to $54.00 and gave the company a “sell” rating in a research note on Monday, August 12th. Morgan Stanley cut their price target on shares of Solventum from $70.00 to $55.00 and set an “equal weight” rating on the stock in a research note on Monday, July 15th. Finally, Wells Fargo & Company cut their price target on shares of Solventum from $69.00 to $64.00 and set an “equal weight” rating on the stock in a research note on Friday, August 9th. One equities research analyst has rated the stock with a sell rating and six have issued a hold rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $58.25.

Solventum Price Performance

Shares of SOLV stock opened at $70.00 on Monday. The stock has a fifty day simple moving average of $58.72. The company has a debt-to-equity ratio of 2.90, a quick ratio of 0.96 and a current ratio of 1.31. Solventum Co. has a 12 month low of $47.16 and a 12 month high of $96.05.

Solventum (NYSE:SOLV) last announced its quarterly earnings data on Thursday, August 8th. The company reported $1.56 EPS for the quarter, topping analysts’ consensus estimates of $1.46 by $0.10. The business had revenue of $2.08 billion during the quarter, compared to the consensus estimate of $2.05 billion. Solventum’s revenue was up .2% compared to the same quarter last year. As a group, sell-side analysts forecast that Solventum Co. will post 6.38 EPS for the current year.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.